Bvf Inc Moon Lake Immunotherapeutics Transaction History
Bvf Inc
- $2.28 Billion
- Q1 2025
A detailed history of Bvf Inc transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Bvf Inc holds 19,751,284 shares of MLTX stock, worth $959 Million. This represents 33.91% of its overall portfolio holdings.
Number of Shares
19,751,284
Previous 19,751,284
-0.0%
Holding current value
$959 Million
Previous $1.05 Billion
26.48%
% of portfolio
33.91%
Previous 39.28%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.3MCall Options Held
481KPut Options Held
229K-
Cormorant Asset Management, LP Boston, MA8.49MShares$412 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$144 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$134 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$71.8 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA1.43MShares$69.7 Million0.29% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.79B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...